Evidence map›Paper›PMID 42180361›Full record

ArticlemedRxiv : the preprint server for health sciences2026

Synonym Augmentation for Rare Disease Identification in Unstructured Data.

Jaber Valinejad, Sungrim Moon, Yanji Xu, Qian Zhu

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jaber ValinejadDivision of Preclinical Innovations, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Rockville, USA.
Sungrim MoonDivision of Preclinical Innovations, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Rockville, USA.
Yanji XuDivision of Rare Disease Research Innovations, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Bethesda, USA.
Qian ZhuDivision of Preclinical Innovations, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Rockville, USA.

Funding

Rare Disease Translational ResearchZIATR000548 · NCATS · NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES · PI MATHÉ, EWY · 2025 to 2025
$897k
Intramural NIH HHS ZIA TR000548
6 · The paper itself

Abstract

The significant challenges associated with rare diseases in the medical and research domains include the scarcity of information, which is often confined to unstructured formats. Although existing approaches provide valuable insights, there is a need to develop effective methods to identify information pertinent to rare diseases for advancing rare disease research. We identified mentions of rare diseases in relevant texts and assessed their relevance using derived scores, the confidence score and semantic similarity from a fine-tuned BioMedBERT encoder. This encoder was fine-tuned using rare disease related text from Online Mendelian Inheritance in Man (OMIM), Orphanet, a manually validated dataset, and STS benchmark datasets. The process of identifying meaningful rare disease mentioned was presented through two case studies that retrieved relevant NIH-funded projects, utilizing a generated knowledge graph in Neo4j to host data on 2,067 GARD diseases with over 320,000 NIH funded projects. Through various case studies with NIH-funded projects related to rare diseases, we demonstrated the effectiveness of our approach in systematically providing rare disease related data to enhance our understanding of rare diseases for future investigations.

Indexed as

Natural Language ProcessingNIH grant funding dataRare disease

Identifiers

PMID42180361
PMCPMC13193144

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.